Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1

Interventions

Specimen Handling 195Magnetic Resonance Spectroscopy 154pembrolizumab 152Carboplatin 115Biopsy 110Cyclophosphamide 100Cisplatin 88Paclitaxel 80Gemcitabine 72Bevacizumab 70fludarabine 61Nivolumab 60Radiotherapy 52Fluorouracil 52Capecitabine 49Dexamethasone 48Pemetrexed 46Rituximab 44Oxaliplatin 44Docetaxel 44Leucovorin 43atezolizumab 42Doxorubicin 42venetoclax 39durvalumab 39Standard of Care 34Prednisone 34Temozolomide 33Radiation 33Cetuximab 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × DEAE-Dextran × 30 days × Clear all
NCT07607119 2026-05-28

PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer

Samsung Medical Center

Phase NA Recruiting
53 enrolled
Gastrointestinal

Stomach Neoplasms

NCT07595172 2026-05-19

NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

West China Hospital

Phase 1/2 Recruiting
55 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡